The University of Texas MD Anderson Cancer Center will host its annual Leading Edge of Cancer Research Symposium November 16-17, 2023, featuring presentations and discussions on genomics, immunity and inflammation, computational approaches for spatial biology, and emerging technologies that are driving the next wave of cancer breakthroughs. More information on the symposium, including a full agenda and links to register or submit posters, can be found at the following link: MDAnderson.org/ResearchSymposium. The in-person symposium at MD Anderson will include keynote presentations from Paul Mischel, MD, Professor of Pathology at Stanford University, Andrea Schietinger, PhD, Associate Professor of Immunology at Memorial Sloan Kettering Cancer Center, and Kevan Shokat, PhD, Chair of Cellular and Molecular Pharmacology at University of California, San Francisco.